Treatment-related Side Effects And Quality Of Life Among Prostate Cancer Patients Treated With Conventional versus Hypofractionated Intensity Mediated Radiotherapy: A Phase III Hypofractionation Trial

被引:6
|
作者
Jean-Pierre, P. [1 ]
Stoyanova, R. [1 ]
Penedo, F. [1 ]
Antoni, M. [1 ]
Abramowitz, M. [1 ]
Buyyounouski, M. [2 ]
Pollack, A. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Fox Chase Canc Ctr, Rockledge, PA USA
关键词
D O I
10.1016/j.ijrobp.2011.06.915
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S667 / S667
页数:1
相关论文
共 50 条
  • [1] Treatment-related side effects and quality of life in cancer patients
    Eva Mazzotti
    Gian Carlo Antonini Cappellini
    Stefania Buconovo
    Roberto Morese
    Alessandro Scoppola
    Claudia Sebastiani
    Paolo Marchetti
    Supportive Care in Cancer, 2012, 20 : 2553 - 2557
  • [2] Treatment-related side effects and quality of life in cancer patients
    Mazzotti, Eva
    Cappellini, Gian Carlo Antonini
    Buconovo, Stefania
    Morese, Roberto
    Scoppola, Alessandro
    Sebastiani, Claudia
    Marchetti, Paolo
    SUPPORTIVE CARE IN CANCER, 2012, 20 (10) : 2553 - 2557
  • [3] Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy A Phase 3 Randomized Clinical Trial
    Bruner, Deborah W.
    Pugh, Stephanie L.
    Lee, W. Robert
    Hall, William A.
    Dignam, James J.
    Low, Daniel
    Swanson, Gregory P.
    Shah, Amit B.
    Malone, Shawn
    Michalski, Jeff M.
    Dayes, Ian S.
    Seaward, Samantha A.
    Nguyen, Paul L.
    Pisansky, Thomas M.
    Chen, Yuhchyau
    Sandler, Howard M.
    Movsas, Benjamin
    JAMA ONCOLOGY, 2019, 5 (05) : 664 - 670
  • [4] Quality of life in prostate cancer patients treated with definitive hypofractionated radiotherapy
    Ma, J.
    Trapp, C.
    Rogowski, P.
    Schmidt-Hegemann, N.
    Belka, C.
    Li, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1250 - S1251
  • [5] Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer
    Naismith, O.
    Mayles, H.
    Bidmead, M.
    Clark, C. H.
    Gulliford, S.
    Hassan, S.
    Khoo, V
    Roberts, K.
    South, C.
    Hall, E.
    Dearnaley, D.
    CLINICAL ONCOLOGY, 2019, 31 (09) : 611 - 620
  • [6] Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy
    Langendijk, Johannes A.
    Doornaert, Patricia
    Verdonck-de Leeuw, Irma M.
    Leemans, Charles R.
    Aaronson, Neil K.
    Slotman, Ben J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) : 3770 - 3776
  • [7] Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial (Feb, 2019)
    Bruner, D.
    Pugh, S. L.
    Lee, W. R.
    Hall, William A.
    JAMA ONCOLOGY, 2019, 5 (05) : 745 - 745
  • [8] A PROSPECTIVE PHASE III RANDOMIZED TRIAL OF HYPOFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN PATIENTS WITH HIGH-RISK PROSTATE CANCER
    Arcangeli, G.
    Arcangeli, S.
    Saracino, B. M.
    Petrongari, M. G.
    Gomellini, S.
    Strigari, L.
    Fowler, J.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S147 - S147
  • [9] A PROSPECTIVE PHASE III RANDOMIZED TRIAL OF HYPOFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN PATIENTS WITH HIGH-RISK PROSTATE CANCER
    Arcangeli, Giorgio
    Saracino, Biancamaria
    Gomellini, Sara
    Petrongari, Maria Grazia
    Arcangeli, Stefano
    Sentinelli, Steno
    Marzi, Simona
    Landoni, Valeria
    Fowler, Jack
    Strigari, Lidia
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 11 - 18
  • [10] A longitudinal assessment of treatment-related differences in quality of life among prostate cancer patients
    Giedzinska-Simons, A.
    Christie, K. M.
    Meyerowitz, B. E.
    Gross, M.
    Agus, D. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)